Endo Internation (ENDP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 ENDO BOULEVARD CHADDS FORD, PA 19317

Develops and markets a portfolio of branded and generic pharmaceutical products primarily for the treatment of pain, including Percocet and Percodan. The company's products are marketed primarily to wholesale drug distributors and chain and independent retail pharmacists.

Data based on most recent fiscal year report
Market Cap1.277 Billion Shares Outstanding223.31 Million Avg Volume10.555 Million
1-Yr BETA vs S&P TR1.312 Current Ratio1.02 Quick Ratio0.85
View SEC Filings from ENDP instead.
Q1 2018 All Institutions Hedge Funds 1
To trade ENDP now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 228 40 (3.78%)
Aggregate 13F shares on 03/31/2018: 218.971 Million 63.131 Million
Aggregate 13F shares on 12/31/2017: 212.567 Million 61.445 Million
Percent change: 3.01% 2.74%
Funds creating new positions: 30 12
Funds Adding to an existing position: 89 12
Funds closing out their position: 37 14
Funds reducing their position: 83 13
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ENDP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Acquired or Disposed Shares Owned Following Transaction Direct/Indirect Ownership

MONTAGUE WILLIAM P - Director

2018-06-08 F 18,507 d 74,888 direct

KIMMEL ROGER H - Director

2018-06-08 A 31,291 a 172,370 direct

HUTSON NANCY J - Director

2018-06-08 F 15,019 d 59,970 direct

MANSUKANI SHARAD - Director

2018-06-08 A 31,291 a 58,559 direct

COOKE SHANE - Director

2018-06-08 F 16,271 d 56,244 direct

MONTAGUE WILLIAM P - Director

2018-06-08 A 41,721 a 93,395 direct

HYATT MICHAEL - Director

2018-06-08 F 15,019 d 279,015 direct

HUTSON NANCY J - Director

2018-06-08 A 31,291 a 74,989 direct

KIMMEL ROGER H - Director

2018-06-08 F 15,019 d 157,351 direct

COOKE SHANE - Director

2018-06-08 A 31,291 a 72,515 direct

MANSUKANI SHARAD - Director

2018-06-08 F 15,019 d 43,540 direct

HYATT MICHAEL - Director

2018-06-08 A 31,291 a 294,034 direct

NICHOL CARRIE ANN - Officer VP, CONTROLLER & CAO

2018-05-26 F 237 d 3,883 direct
Click here to report any possible errors with this stock listing.

Elevate your investments